Irinotecan, carboplatin, and imatinib in extensive stage small cell lung cancer: A phase II trial of the Minnie Pearl Cancer Research Network.

被引:0
|
作者
Raefsky, EL
Hainsworth, JD
Rinaldi, D
Schreeder, M
Spigel, DR
Burris, HA
Yardley, DA
Thompson, DS
Greco, FA
机构
[1] Sarah Cannon Canc Ctr, Tennessee Oncol, Nashville, TN USA
[2] Louisiana Oncol Assoc, Lafayette, LA USA
[3] Comprehens Canc Inst, Huntsville, AL USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
7300
引用
收藏
页码:691S / 691S
页数:1
相关论文
共 50 条
  • [1] Irinotecan, carboplatin, and imatinib in untreated extensive-stage small-cell lung cancer: A phase II trial of the minnie pearl cancer research network
    Spigel, David R.
    Hainsworth, John D.
    Simons, Lisa
    Meng, Christina
    Burris, Howard A., III
    Yardley, Denise A.
    Grapski, Richard
    Schreeder, Marshall
    Mallidi, Padmaja V.
    Greco, F. Anthony
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (09) : 854 - 861
  • [2] Irinotecan (I), carboplatin (C), and imatinib (IM) in the first-line treatment of extensive-stage small cell lung cancer (SCLC): A phase II trial of the Minnie Pearl Cancer Research Network.
    Thompson, DS
    Hainsworth, JD
    Spigel, DR
    Toomey, MA
    Rubin, MS
    Schreeder, MT
    Mateer, S
    Greco, FA
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 632S - 632S
  • [3] Irinotecan (I), carboplatin (C), and radiotherapy (RT) followed by bevacizumab (B) in the treatment of limited-stage small cell lung cancer (SCLC): A phase II trial of the Minnie Pearl Cancer Research Network.
    Raefsky, EL
    Spigel, DR
    Greco, FA
    Yardley, DA
    Bradof, JE
    Woytowitz, DV
    Schreeder, MT
    Liggett, WH
    Zubkus, JD
    Petrone, D
    Hainsworth, JD
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 633S - 633S
  • [4] Paclitaxel/carboplatin/etoposide versus paclitaxel/topotecan for extensive stage small cell lung cancer: A Minnie Pearl Cancer Research Network randomized prospective phase II trial.
    Thompson, DS
    Hainsworth, JD
    Morrissey, LH
    Erland, JB
    Burris, HA
    Joseph, G
    Corso, SW
    Spremulli, E
    Greco, FA
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 667S - 667S
  • [5] Paclitaxel/carboplatin/etoposide versus paclitaxel/topotecan for extensive-stage small cell lung cancer: A minnie pearl cancer research network randomized, prospective phase II trial
    Greco, FA
    Thompson, DS
    Morrissey, LH
    Erland, JB
    Burris, HA
    Spigel, DR
    Joseph, G
    Corso, SW
    Spremulli, E
    Hainsworth, JD
    ONCOLOGIST, 2005, 10 (09): : 728 - 733
  • [6] Weekly bolus topotecan as secondary therapy in extensive stage small cell lung cancer: A Minnie Pearl Cancer Research Network phase II trial.
    Peacock, NW
    Hainsworth, JD
    Switzer, AB
    Burris, HA
    Barrett, C
    Nicolau, MF
    Greco, FA
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 685S - 685S
  • [7] Paclitaxel, carboplatin, and topotecan in the treatment of patients with small cell lung carcinoma - A phase II trial of the Minnie Pearl Cancer Research Network
    Hainsworth, JD
    Morrissey, LH
    Scullin, DC
    Houston, GA
    Prasthofer, EF
    Gray, JR
    Burris, HA
    Greco, FA
    CANCER, 2002, 94 (09) : 2426 - 2433
  • [8] Paclitaxel, carboplatin, and vinorelbine in the treatment of advanced non-small cell lung cancer: A phase II trial of the Minnie Pearl Cancer Research Network
    Hainsworth, JD
    Burris, HA
    Morrissey, LH
    Thomas, M
    Erland, JB
    Butts, JA
    Joseph, G
    Kalman, L
    Greco, FA
    CANCER JOURNAL, 2000, 6 (03): : 151 - 156
  • [9] Phase II trial of irinotecan, carboplatin, and bevacizumab in patients with extensive-stage small cell lung cancer
    Spigel, D. R.
    Hainsworth, J. D.
    Yardley, D. A.
    Burris, H. A., III
    Farley, C.
    Zubkus, J.
    Meng, C.
    Murphy, P.
    Saez, R.
    Greco, F. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [10] A Phase II Study of Carboplatin and Irinotecan in Extensive Stage Small-Cell Lung Cancer
    Horn, Leora
    Zhao, Zhiguo
    Sandler, Alan
    Johnson, David
    Shyr, Yu
    Wolff, Steven
    DeVore, Russell F.
    Laskin, Janessa
    CLINICAL LUNG CANCER, 2011, 12 (03) : 161 - 165